← All filings
Withdrawn · Form C-W
A withdrawal — the company pulled its offering, sometimes just hours later to fix a mistake.
Sarcomatrix Therapeutics Corp
Filed Aug 13, 2025
Sarcomatrix Therapeutics Corp filed a Form C-W — withdrawn — with the SEC on Aug 13, 2025.
Open the official record on EDGAR for this filing’s documents.
View the official filing on SEC EDGAR →
In the news · Sarcomatrix Therapeutics Corp
Sarcomatrix Therapeutics Accredited Investor Round Scheduled to Close October 31 (Oct 22, 2026)
Sarcomatrix Therapeutics Extends Accredited Investor Round to October 31 (Sep 30, 2026)
Sarcomatrix Therapeutics Provides Business Update: Board Expanded, Regulatory and Manufacturing Partners Engaged Across Two Rare Neuromuscular Programs (Sep 11, 2026)
The New Rules of Biotech Now Available in Hardcover and Audiobook (Jul 3, 2026)
SuperImpactScore.ai
Doing diligence on a Reg CF offering?
Get an AI-powered due-diligence report on any live Regulation Crowdfunding offering — real web research with verified claims, delivered in minutes for $12 — or free with Impact Membership.
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.